Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring

por Kjeldsen, Sverre E., Aksnes, Tonje A., Ruilope, Luis M.
Publicado 2014

Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses

por Kjeldsen, Sverre E., Cha, Gloria, Villa, Giuseppe, Mancia, Giuseppe
Publicado 2016

Expert ethos and the strength of networks: negotiations of credibility in mediated debate on COVID-19

por Kjeldsen, Jens E, Ihlen, Øyvind, Just, Sine N, Larsson, and Anders Olof
Publicado 2021

Blood pressure control and components of the metabolic syndrome: the GOOD survey

por Zidek, Walter, Naditch-Brûlé, Lisa, Perlini, Stefano, Farsang, Csaba, Kjeldsen, Sverre E
Publicado 2009

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

por Kjeldsen, S E, Stålhammar, J, Hasvold, P, Bodegard, J, Olsson, U, Russell, D
Publicado 2010

Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension

por Okin, Peter M., Hille, Darcy A., Kjeldsen, Sverre E., Devereux, Richard B.
Publicado 2017

Influence of Unequal Amplification of Methylated and Non-Methylated Template on Performance of Pyrosequencing

por Taryma-Lesniak, Olga, Kjeldsen, Tina E., Hansen, Lise Lotte, Wojdacz, Tomasz K.
Publicado 2022

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?

por Persu, Alexandre, Stoenoiu, Maria S, Maes, Frédéric, Kreutz, Reinhold, Mancia, Giuseppe, Kjeldsen, Sverre E
Publicado 2023

Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke

por Kjeldsen, Sverre E, Lyle, Paulette A, Kizer, Jorge R, Oparil, Suzanne, Høieggen, Aud, Os, Ingrid
Publicado 2007

Hypertension and Genetic Variation in Endothelial-Specific Genes

por Larsson, Erik, Wahlstrand, Björn, Hedblad, Bo, Hedner, Thomas, Kjeldsen, Sverre E., Melander, Olle, Lindahl, Per
Publicado 2013

Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial

por Mancia, G, Cha, G, Gil-Extremera, B, Harvey, P, Lewin, A J, Villa, G, Kjeldsen, S E
Publicado 2017

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients

por Hasvold, L P, Bodegård, J, Thuresson, M, Stålhammar, J, Hammar, N, Sundström, J, Russell, D, Kjeldsen, S E
Publicado 2014

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

por Hasvold, Pål, Thuresson, Marcus, Sundström, Johan, Hammar, Niklas, Kjeldsen, Sverre E., Johansson, Gunnar, Holme, Ingar, Bodegård, Johan
Publicado 2015

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma

por Daugaard, Iben, Dominguez, Diana, Kjeldsen, Tina E., Kristensen, Lasse S., Hager, Henrik, Wojdacz, Tomasz K., Hansen, Lise Lotte
Publicado 2016

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension

por Fadl Elmula, Fadl Elmula M., Larstorp, Anne C., Kjeldsen, Sverre E., Persu, Alexandre, Jin, Yu, Staessen, Jan A.
Publicado 2015

Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma

por Daugaard, Iben, Venø, Morten T., Yan, Yan, Kjeldsen, Tina E., Lamy, Philippe, Hager, Henrik, Kjems, Jørgen, Hansen, Lise Lotte
Publicado 2017

Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle‐Aged Men: a 28‐Year Follow‐Up Study

por Engeseth, Kristian, Hodnesdal, Christian, Grundvold, Irene, Liestøl, Knut, Gjesdal, Knut, Kjeldsen, Sverre E., Erikssen, Jan E., Bodegard, Johan, Skretteberg, Per Torger
Publicado 2016

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results

por Kjeldsen, Sverre E., Sica, Domenic, Haller, Hermann, Cha, Gloria, Gil-Extremera, Blas, Harvey, Peter, Heyvaert, Frank, Lewin, Andrew J., Villa, Giuseppe, Mancia, Giuseppe
Publicado 2014

IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load

por Hussmann, Dianna, Starnawska, Anna, Kristensen, Louise, Daugaard, Iben, Thomsen, Astrid, Kjeldsen, Tina E., Hansen, Christine Søholm, Bybjerg-Grauholm, Jonas, Johansen, Karina Dalsgaard, Ludvigsen, Maja, Kristensen, Thomas, Larsen, Thomas Stauffer, Møller, Michael Boe, Nyvold, Charlotte Guldborg, Hansen, Lise Lotte, Wojdacz, Tomasz K.
Publicado 2021

Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7‐Year Follow‐Up of Patients Considered Adherent by Directly Observed Therapy

por Halvorsen, Lene V., Bergland, Ola U., Søraas, Camilla L., Larstorp, Anne Cecilie K., Hjørnholm, Ulla, Kjær, Vibeke N., Kringen, Marianne K., Clasen, Per‐Erik, Haldsrud, Renate, Kjeldsen, Sverre E., Rostrup, Morten, Fadl Elmula, Fadl Elmula M., Opdal, Mimi S., Høieggen, Aud
Publicado 2022